CMT 64 Cell Line
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (4)
- Inventor Info
Info
| Catalogue Number | 151447 |
| Host | Mouse |
| Tissue | Lung |
| Disease Keywords | Lung carcinoma, metastatic |
| Model | Tumour line |
| Relevance | The tumourigenic and metastatic CMT 64 murine cell line is an in vivo mouse tumourigenesis system to study the growth characteristics and metastasis of mouse tumour lines (homoplastic with stable CMT 167 line); it demonstrates stable growth characteristics and morphology in culture and in lung metastasis induced after subcutaneous inoculation of mice. |
| Production Details | Mouse; CMT 64 isolated from primary alveogenic lung carcinoma tumour mass in C57BL/lcrf mouse, achieving stable morphology and growth rate in culture, similar to growth rate and morphology in primary tumour, and in lung metastasis induced after subcutaneous innoculation of mice. |
| Research Area | Cancer, Drug Discovery & Development |
| Growth/Phenotype Keywords | Tumorigenesis |
| Recommended Growing Conditions | CMT 64 cell line can be grown in DMEM with 10% FCS, supplemented with 20mM Hepes. |
| Cellosaurus ID | CVCL_2406 |
References: 4 entries
Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
Europe PMC ID: 28525366
Rincón et al. 2017. Oncotarget. :. PMID: 28525366.
Franks et al. 1976. Cancer Res. 36(3):1049-55. PMID: 1253168.
Metastasizing tumors from serum-supplemented and serum-free cell lines from a C57BL mouse lung tumor.
Europe PMC ID: 1253168
Add a reference
References: 4 entries
Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
Rincón et al. 2017. Oncotarget. :. PMID: 28525366.
Franks et al. 1976. Cancer Res. 36(3):1049-55. PMID: 1253168.
Metastasizing tumors from serum-supplemented and serum-free cell lines from a C57BL mouse lung tumor.
Add a reference
